Mineralys Therapeutics In... (MLYS)
NASDAQ: MLYS
· Real-Time Price · USD
14.51
0.38 (2.69%)
At close: Aug 15, 2025, 3:59 PM
14.52
0.10%
After-hours: Aug 15, 2025, 04:20 PM EDT
Mineralys Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
PE Ratio | -5.12 | -5 | -3.14 | -2.68 | -3.66 | -4.64 | -3.53 | -4.17 | -12.27 | -7.69 | -2.65 | -3.58 | -3.66 | -3.12 | -3.29 |
PEG Ratio | 0.31 | 0.26 | 0.24 | -0.07 | -0.2 | -0.31 | -0.5 | -0.05 | 0.31 | 0.11 | -0.08 | -1.5 | 0.25 | -0.55 | n/a |
PS Ratio | n/a | n/a | 18.09K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.82 | 2.47 | 3.22 | 2.55 | 2.07 | 1.78 | 1.43 | 1.44 | 2.09 | 1.31 | -1.84 | -2.2 | n/a | 15.56 | -4.07 |
P/FCF Ratio | -29.35 | -18.56 | -9.2 | -12.01 | -19.93 | -30.47 | -11.9 | -19.95 | -29.23 | -30.36 | -9.43 | -13.67 | -17.34 | -14.36 | -19.08 |
P/OCF Ratio | -29.35 | -18.56 | -9.2 | -12.02 | -19.93 | -30.57 | -11.9 | -19.95 | -29.23 | -30.36 | -9.43 | -13.67 | -17.34 | -14.36 | -19.08 |
OCF/S Ratio | n/a | n/a | -1.97K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 15.12 | 26.48 | 14.02 | 8.55 | 11.20 | 18.06 | 23.76 | 19.59 | 43.42 | 26.07 | 13.65 | 16.88 | n/a | n/a | 2.20 |
Current Ratio | 15.12 | 26.48 | 14.02 | 8.55 | 11.20 | 18.06 | 23.76 | 19.59 | 43.42 | 26.07 | 13.65 | 16.88 | n/a | n/a | 2.20 |
Asset Turnover | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.14 | -0.12 | -0.26 | -0.24 | -0.14 | -0.1 | -0.1 | -0.09 | -0.04 | -0.04 | 0.17 | 0.15 | n/a | -1.25 | 0.31 |
Return on Assets | -0.13 | -0.12 | -0.24 | -0.21 | -0.13 | -0.09 | -0.1 | -0.08 | -0.04 | -0.04 | -0.08 | -0.05 | n/a | n/a | -0.64 |
Return on Invested Capital | -0.15 | -0.13 | -0.27 | -0.25 | -0.16 | -0.11 | -0.11 | -0.1 | -0.06 | -0.05 | -0.09 | -0.06 | n/a | n/a | -1.17 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -1.44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -1.44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -1.52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -1.52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |